Effectiveness of a Hospital School Mathematics Literacy Program

To receive treatment for cancer, patients in Brazil often travel to larger hospitals that may be located far away from their families and communities. Pediatric patients miss time in the classroom and may achieve educational milestones later than other students. They may also struggle with some educational topics after receiving certain types of cancer treatment. the Hospital School at the GRAACC helps to close this education gap by providing educational support to school-age students receiving treatment for cancer. in addition to providing educational services during treatment, teachers at the hospital school, Mobile School -Specific Student (EMAE). the objective of this preliminary study is to build knowledge about the impact of school enrollment on mathematics literacy in hospitalized cancer patients undergoing treatment. We followed 15-year-old patients (n = 54) with at last 1 year inside the hospital school for a period of 8 years (2001-2008). Study participants were affected by a variety of diseases including bone tumors (n = 39), Hodgkin lymphoma (n = 08) and non-Hodgkin lymphoma (n = 07). the level of participants' mathematical literacy was regularly assessed by reviewing the results of formative assessments completed by students. Using that information, students were grouped into categories according to mathematics literacy levels established by the Programme for International Student Assessment (PISA). the formative assessment is based on the analysis of all the material produced by the student and the EMAE teacher across the years of the study, including the recordings of working meetings that were held with all the teachers every class day.Universidade Federal de São Paulo, Inst Pediat Oncol, Support Grp Children & Adolescents Canc, São Paulo, BrazilUniv Estadual Campinas, Inst Comp, Campinas, BrazilUniversidade Federal de São Paulo, Inst Pediat Oncol, Support Grp Children & Adolescents Canc, São Paulo, BrazilWeb of Scienc

Canonical microcircuits for predictive coding

Item does not contain fulltex

30-Day Morbidity and Mortality of Bariatric Surgery During the COVID-19 Pandemic: a Multinational Cohort Study of 7704 Patients from 42 Countries.

BACKGROUND There are data on the safety of cancer surgery and the efficacy of preventive strategies on the prevention of postoperative symptomatic COVID-19 in these patients. But there is little such data for any elective surgery. The main objectives of this study were to examine the safety of bariatric surgery (BS) during the coronavirus disease 2019 (COVID-19) pandemic and to determine the efficacy of perioperative COVID-19 protective strategies on postoperative symptomatic COVID-19 rates. METHODS We conducted an international cohort study to determine all-cause and COVID-19-specific 30-day morbidity and mortality of BS performed between 01/05/2020 and 31/10/2020. RESULTS Four hundred ninety-nine surgeons from 185 centres in 42 countries provided data on 7704 patients. Elective primary BS (n = 7084) was associated with a 30-day morbidity of 6.76% (n = 479) and a 30-day mortality of 0.14% (n = 10). Emergency BS, revisional BS, insulin-treated type 2 diabetes, and untreated obstructive sleep apnoea were associated with increased complications on multivariable analysis. Forty-three patients developed symptomatic COVID-19 postoperatively, with a higher risk in non-whites. Preoperative self-isolation, preoperative testing for SARS-CoV-2, and surgery in institutions not concurrently treating COVID-19 patients did not reduce the incidence of postoperative COVID-19. Postoperative symptomatic COVID-19 was more likely if the surgery was performed during a COVID-19 peak in that country. CONCLUSIONS BS can be performed safely during the COVID-19 pandemic with appropriate perioperative protocols. There was no relationship between preoperative testing for COVID-19 and self-isolation with symptomatic postoperative COVID-19. The risk of postoperative COVID-19 risk was greater in non-whites or if BS was performed during a local peak

Safety of Bariatric Surgery in ≥ 65-Year-Old Patients During the COVID-19 Pandemic

Background Age >= 65 years is regarded as a relative contraindication for bariatric surgery. Advanced age is also a recognised risk factor for adverse outcomes with Coronavirus Disease-2019 (COVID-19) which continues to wreak havoc on global populations. This study aimed to assess the safety of bariatric surgery (BS) in this particular age group during the COVID-19 pandemic in comparison with the younger cohort.Methods We conducted a prospective international study of patients who underwent BS between 1/05/2020 and 31/10/2020. Patients were divided into two groups - patients >= 65-years-old (Group I) and patients < 65-years-old (Group II). The two groups were compared for 30-day morbidity and mortality.Results There were 149 patients in Group 1 and 6923 patients in Group II. The mean age, preoperative weight, and BMI were 67.6 +/- 2.5 years, 119.5 +/- 24.5 kg, and 43 +/- 7 in Group I and 39.8 +/- 11.3 years, 117.7 +/- 20.4 kg, and 43.7 +/- 7 in Group II, respectively. Approximately, 95% of patients in Group 1 had at least one co-morbidity compared to 68% of patients in Group 2 (p = < 0.001). The 30-day morbidity was significantly higher in Group I ( 11.4%) compared to Group II (6.6%) (p = 0.022). However, the 30-day mortality and COVID-19 infection rates were not significantly different between the two groups.Conclusions Bariatric surgery during the COVID-19 pandemic is associated with a higher complication rate in those >= 65 years of age compared to those < 65 years old. However, the mortality and postoperative COVID-19 infection rates are not significantly different between the two groups